Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spero Therapeutics, Inc. | 742,506 | reported | 06 Feb 2026 | tx 22+1,204,530−161,902 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Feb 2026 | SALE | Spero Therapeutics, Inc. | 18,652 | 2.36 USD | |
| 04 Feb 2026 | SALE | Spero Therapeutics, Inc. | 3,471 | 2.24 USD | |
| 03 Feb 2026 | SALE | Spero Therapeutics, Inc. | 24,224 | 2.14 USD | |
| 02 Feb 2026 | SALE | Spero Therapeutics, Inc. | 18,891 | 2.20 USD | |
| 02 Feb 2026 | GRANT_AWARD | Spero Therapeutics, Inc. | 68,000 | 0.00 USD | |
| 02 Feb 2026 | GRANT_AWARD | Spero Therapeutics, Inc. | 137,000 | 0.00 USD | deriv |
| 28 Aug 2025 | SALE | Spero Therapeutics, Inc. | 1,695 | 1.97 USD | |
| 03 Feb 2025 | GRANT_AWARD | Spero Therapeutics, Inc. | 266,139 | 0.00 USD | |
| 05 Feb 2025 | SALE | Spero Therapeutics, Inc. | 24,920 | 0.78 USD | |
| 05 Feb 2025 | SALE | Spero Therapeutics, Inc. | 27,643 | 0.78 USD | |
| 05 Feb 2025 | SALE | Spero Therapeutics, Inc. | 3,974 | 0.78 USD | |
| 27 Aug 2024 | SALE | Spero Therapeutics, Inc. | 2,213 | 1.35 USD | |
| 01 Feb 2024 | GRANT_AWARD | Spero Therapeutics, Inc. | 239,731 | 0.00 USD | |
| 02 Feb 2024 | SALE | Spero Therapeutics, Inc. | 30,971 | 1.36 USD | |
| 28 Aug 2023 | SALE | Spero Therapeutics, Inc. | 1,854 | 1.26 USD | |
| 01 Feb 2023 | GRANT_AWARD | Spero Therapeutics, Inc. | 265,957 | 0.00 USD | |
| 02 Feb 2023 | SALE | Spero Therapeutics, Inc. | 3,394 | 1.86 USD | |
| 01 Feb 2022 | GRANT_AWARD | Spero Therapeutics, Inc. | 38,014 | 0.00 USD | |
| 01 Feb 2022 | GRANT_AWARD | Spero Therapeutics, Inc. | 53,190 | 0.00 USD | deriv |
| 26 Aug 2021 | GRANT_AWARD | Spero Therapeutics, Inc. | 24,067 | 0.00 USD | |
| 01 Feb 2021 | GRANT_AWARD | Spero Therapeutics, Inc. | 57,432 | 0.00 USD | deriv |
| 03 Feb 2020 | GRANT_AWARD | Spero Therapeutics, Inc. | 55,000 | 0.00 USD | deriv |